CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer

BACKGROUND: Successful neoadjuvant chemotherapy (NACT) could improve the surgical resection rate and radical curability of patients with cervical cancer, but only a subset of patients benefits. Therefore, identifying predictive biomarkers are urgently needed. The aim of this study was to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yun, Li, Zhi, Liu, Mubiao, Ye, Haiyan, He, Jianhui, Chen, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Gynecologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277608/
https://www.ncbi.nlm.nih.gov/pubmed/33392721
http://dx.doi.org/10.1007/s00404-020-05921-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277608/
https://www.ncbi.nlm.nih.gov/pubmed/33392721
http://dx.doi.org/10.1007/s00404-020-05921-8

Ejemplares similares